-transparent.png){kind=logo}
Lecanoric acid analogues containing benzanilide structure inhibited histidine decarboxylase and arachidonic acid release from the cell membrane phospholipids induced by a tumour promoter, 12-O-tetradecanoylphorbol-13-acetate. But they did not inhibit cellular binding of phorbol-12,13-dibutylate. Lecanoric acid analogues also inhibited prostaglandin synthetase and delayed-type hypersensitivity responses against sheep red blood cells in mice. Thus, lecanoric acid analogues antagonized several enzymic and cellular effects of the tumour promoter.
Related Publications
K Umezawa, and
S Muramatsu, and
M Ishizuka, and
T Sawa, and
T Takeuchi, and
T Matsushima
August 1974,
The Journal of antibiotics,
K Umezawa, and
S Muramatsu, and
M Ishizuka, and
T Sawa, and
T Takeuchi, and
T Matsushima
April 1981,
Biochemical and biophysical research communications,
K Umezawa, and
S Muramatsu, and
M Ishizuka, and
T Sawa, and
T Takeuchi, and
T Matsushima
May 1977,
Journal of medicinal chemistry,
K Umezawa, and
S Muramatsu, and
M Ishizuka, and
T Sawa, and
T Takeuchi, and
T Matsushima
March 1992,
Toxicology in vitro : an international journal published in association with BIBRA,
K Umezawa, and
S Muramatsu, and
M Ishizuka, and
T Sawa, and
T Takeuchi, and
T Matsushima
January 1984,
Experientia,
K Umezawa, and
S Muramatsu, and
M Ishizuka, and
T Sawa, and
T Takeuchi, and
T Matsushima
November 1984,
The American review of respiratory disease,
K Umezawa, and
S Muramatsu, and
M Ishizuka, and
T Sawa, and
T Takeuchi, and
T Matsushima
August 1988,
Biochimica et biophysica acta,
K Umezawa, and
S Muramatsu, and
M Ishizuka, and
T Sawa, and
T Takeuchi, and
T Matsushima
March 1981,
Journal of pharmaceutical sciences,
K Umezawa, and
S Muramatsu, and
M Ishizuka, and
T Sawa, and
T Takeuchi, and
T Matsushima
April 1977,
Journal of medicinal chemistry,
K Umezawa, and
S Muramatsu, and
M Ishizuka, and
T Sawa, and
T Takeuchi, and
T Matsushima
September 1969,
Annals of the New York Academy of Sciences,
